Lexaria Attending the BIO International Convention, as part of a Broader Business Development Program

Kelowna, British Columbia - June 3 , 2026 – TheNewswire - Lexaria Bioscience Corp. (NASDAQ: LEXX) (“Lexaria” or the “Company”), a global innovator in oral drug delivery platforms , announces that it is attending the BIO International Convention (“BIO”) from June 22-25 in San Diego, CA . Lexaria's attendance at last year's 2025 BIO convention served as a catalyst for its greatly expanded business development (“BD”) program that is now starting to deliver positive results and which Lexaria intends to build upon at this year's BIO conference.   “We are experiencing record-high levels of business development and collaboration interest in our DehydraTECH platform, even before the upcoming BIO conference,” said Richard Christopher, CEO of Lexaria Bioscience. “New business relationships require intense energy and scientific evaluation from both prospective partners to discover the best fit possible. We are working tirelessly in this regard with the intent of generating positive developments that we can publicly discuss.”